[Therapy of hyperthyroidism with Na 131I]. 1984

H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
February 1977, Kaku igaku. The Japanese journal of nuclear medicine,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
January 1987, Acta medica Hungarica,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
October 2006, Clinical endocrinology,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
January 1981, Acta radiologica. Oncology,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
November 1963, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
June 1984, Nuklearmedizin. Nuclear medicine,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
March 1979, Rinsho hoshasen. Clinical radiography,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
October 2007, Arquivos brasileiros de endocrinologia e metabologia,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
January 1976, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
H Kakehi, and T Furukawa, and S Fukakusa, and H Futonaka, and Y Takahashi
December 1982, Journal of the Indian Medical Association,
Copied contents to your clipboard!